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Introduction
Soluble guanylate cyclase (sGC), the main target of nitric
oxide (NO), has been proven to have a significant role in
coronary artery disease, pulmonary hypertension, erectile
dysfunction and myocardial infarction. Several drugs that
increase the activity of this enzyme are now in clinical
phase of development: some of them are heme-dependent
and might interact with the catalytic domain and others
are heme-independent and supposedly bind to the sensory
domain. The absence of reliable structural information is
one of the factors that have precluded knowledge of the
precise site of interaction of these molecules and of the
mechanism of activation of the enzyme.
Methods
Homology models of the catalytic domain of sGC in ‘inac-
tive’ or ‘active’ conformation were constructed using, for
the b-chain, the structure of recently published crystal of a
nonphysiological homodimer of b subunits of human gua-
nylate cyclase (2WZ1), for the a-chain, a similar domain
of the green algae Chlamydomonas reinhardtii (3ET6)
and, for monomer arrangement, the sGC ‘inactive’ struc-
ture (3ET6) or the ‘active’ catalytic domain of adenylate
cyclase (1CJU). Molecular dynamics simulations of about
1μs each where run on all relevant models (NAMD/
ACEMD, Amber99SB).
Results
In the different trajectories, sGC conformation varied
between having 1CJU- and 3ET6-like structures. One of
these trajectories maintained extremely stable relative
positions of the aminoacids in the catalytic site, being
very similar to those described in 1CJU. The observed
conformational transitions suggest a possible mechanism
for the transmission of the cooperativity signal between
the pseudo-symmetric and the catalytic site, in which
Arg-92 (a-chain) and Arg-539 (b-chain) and the loop
b2-b3 seem to play a critical role.
Conclusions
Docking of YC-1, a classic heme-dependent activator, to
all frames of this trajectory and absolute binding free
energies with the linear interaction energy method (LIE)
for selected poses revealed one potential binding site
located between pseudo-symmetric and catalytic sites
just over the loop b2-b3. This site would be compatible
with the binding of a second GTP or an inhibitory ATP
to the pseudo-symmetric site.
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